Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matthews Asia, now branded more broadly as Matthews, is an independent, privately owned investment manager focused on Asia and global emerging markets. The firm offers actively managed investment products, including mutual funds, ETFs and related strategies, for institutions, financial advisors and individual investors. Founded in 1991, the business is known for bottom-up fundamental research and a long-term active investment approach rather than drug development or healthcare services. Its operations are centered in San Francisco with additional international offices supporting research and client coverage. For biotech and healthcare classification purposes, this is a financial services company, not a life sciences, biotech, pharma or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matthews Asia.